5 Brevetto
 Distribuzione geografica
Continente #
EU - Europa 11.519
NA - Nord America 9.113
AS - Asia 4.970
SA - Sud America 204
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 58
OC - Oceania 9
Totale 26.034
Nazione #
US - Stati Uniti d'America 9.014
NL - Olanda 3.816
GB - Regno Unito 2.350
CN - Cina 2.146
IT - Italia 1.542
SG - Singapore 1.132
UA - Ucraina 887
SE - Svezia 835
JP - Giappone 673
DE - Germania 499
TR - Turchia 491
FR - Francia 369
RU - Federazione Russa 312
FI - Finlandia 309
VN - Vietnam 221
IE - Irlanda 166
BR - Brasile 155
AT - Austria 130
BE - Belgio 100
PL - Polonia 79
IN - India 73
CA - Canada 66
EU - Europa 61
KR - Corea 56
BD - Bangladesh 43
ES - Italia 32
HK - Hong Kong 28
AR - Argentina 25
RO - Romania 22
MX - Messico 19
ZA - Sudafrica 14
IQ - Iraq 13
KE - Kenya 13
LT - Lituania 11
MA - Marocco 10
PT - Portogallo 10
CH - Svizzera 9
ID - Indonesia 9
PK - Pakistan 9
JO - Giordania 8
SA - Arabia Saudita 8
AU - Australia 7
TG - Togo 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
EC - Ecuador 6
MY - Malesia 6
IR - Iran 5
PH - Filippine 5
AL - Albania 4
BG - Bulgaria 4
DK - Danimarca 4
EE - Estonia 4
IL - Israele 4
KZ - Kazakistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
CO - Colombia 3
CZ - Repubblica Ceca 3
HR - Croazia 3
KG - Kirghizistan 3
LV - Lettonia 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
CR - Costa Rica 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
ET - Etiopia 1
GD - Grenada 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
Totale 25.922
Città #
Amsterdam 3.793
Southend 2.184
Dallas 1.913
Chandler 823
Jacksonville 683
Ann Arbor 650
Ashburn 604
San Jose 585
Singapore 537
Nanjing 491
Houston 391
Izmir 364
Woodbridge 362
Urbino 333
Beijing 329
Boardman 185
Nanchang 174
Munich 165
Dublin 153
Wilmington 148
New York 147
Helsinki 140
Düsseldorf 136
Vienna 128
San Mateo 122
Dong Ket 106
Princeton 104
Lauterbourg 102
Council Bluffs 100
Des Moines 100
Brussels 98
Los Angeles 95
Orciano Di Pesaro 92
Kunming 90
Cambridge 83
Jiaxing 74
Shenyang 69
Tianjin 69
Fairfield 67
Istanbul 66
Hebei 65
Milan 64
Santa Clara 64
Changsha 62
Moscow 60
Velikiy Novgorod 57
Seongnam 52
Kraków 50
Shanghai 47
Ho Chi Minh City 41
Hangzhou 40
Buffalo 38
Rome 38
Bremen 36
Lanzhou 33
Frankfurt am Main 32
Paris 32
Seattle 32
Jinan 31
Tokyo 31
Toronto 31
Venice 29
Ancona 27
Wuppertal 26
Hanoi 25
Changchun 23
San Francisco 23
The Dalles 23
Turku 23
Warsaw 23
Dearborn 21
Hong Kong 21
Guangzhou 20
Montreal 20
Stockholm 20
Brooklyn 18
Civitanova Marche 18
West Jordan 18
Atlanta 17
Chicago 17
Ningbo 16
Zhengzhou 16
Bologna 15
Florence 15
London 15
Poplar 15
Denver 14
Nuremberg 14
Orem 14
Redwood City 14
Boston 13
Manchester 13
Phoenix 13
Chennai 12
Dormagen 12
Ascoli Piceno 11
Johannesburg 11
Macerata 11
Mexico City 11
São Paulo 11
Totale 18.469
Nome #
1,5-BENZODIAZEPINE-2,4-DIONE GASTRIN AND CHOLECYSTOKININ-B-RECEPTOR ANTAGONISTS 3.153
1,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(3H)-ONE DERIVATIVES, AND THEIR USE AS ANTICONVULSANT AND ANTIANXIETY AGENTS 3.153
Derivative of [(3-hydroxy-4-pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs 356
Metodo di sintesi di derivati del glutatione [Method for the synthesis of glutathione derivatives] 333
DEVICE FOR EMULATING ENERGY SOURCES USED TO POWER EMBEDDED SYSTEMS/DEVICES 323
Device and single-molecule analysis method by means of detection of the collisions of a target molecule on functionalized nanopores 322
Pharmaceutical composition of [(3-​hydroxy-​4 -​pyron-​2-​yl) methyl] -​amine derivatives and DNA demethylating agents and their use as anti-​neoplastic drugs 293
Microfluidic-formulated leukosome compositions and fabrication methods therefor 285
METHOD FOR PRODUCING OPTICALLY ACTIVE 1,2-DIAMINE COMPOUND AND OPTICALLY ACTIVE NIOBIUM CATALYST 259
10-(1-HYDROXYMETHYL)-11-OXO-1-AZATRICYCLOUNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS USEFUL AS ANTIBACTERIAL AND PROCESS FOR THEIR PREPARATION 256
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell'aria 252
2,4,5-TRISUBSTITUTED OXAZOLES 248
SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED 246
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 245
Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment 243
Corpo cavo di Sonda geotermica e Sonda geotermica 237
Drug delivery systems 236
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 235
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 235
Acyclovir prodrug and its use in pharmaceutical compositions 235
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 235
5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors, preparation, and therapeutic use.. 228
Attrezzo ginnico sportivo 226
Method And Relative Test Structure For Measuring The Coupling Capacitance Between Two Interconnect Lines 226
TEICOPLANIN HYDRAZIDES AS ANTIBACTERIALS 225
Uso del Sulodexide per la riduzione delle metalloproteasi di matrice 225
Processo per la preparazione di esteri degli acidi 2-aril-alcanoici 223
Control system of acoustic echo cancellers for telephone terminals with handset or handsfree 221
3,6-DISUBSTITUTED TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES 220
5-fluorocitosina come agente antibatterico 219
Peripherally Restricted FAAH Inhibitors 217
Production of triterpenic acids by in vitro culture of calluses deriving from the pulp of red sentinel apples 215
Biomimetic proteolipid vesicle compositions and uses thereof 214
Delivery of Contrasting Agents for Magnetic Resonance Imaging 213
Procedimento perfezionato per la riduzione di composti organici mediante l'impiego di idruro di magnesio 210
Pharmaceutical composition for the parenteral administration of melatonin, and a process for its preparation 209
A process for the preparation of monosialoganglioside by autolysis of cattle brain. 208
Filtro per l’equalizzazione e/o la Linearizzazione sistemi non lineari 207
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell’aria 205
DEVICE FOR GENERATING MICRO- AND NANO-FLOW MOBILE PHASE GRADIENTS FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 204
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 204
Procedimento per la preparazione di monosialoganglioside 203
“Tretamerous derivative of indole-3-carbinol with anticancer activity and method of synthesis of said derivative “ 201
Procedimento per la preparazione di biopolimeri 198
Procedimento per ottenere una sostanza antiossidante da peci fenoliche. 195
Nanoparticles for delivery of a pharmacologically active agent 193
5-fluorocitosina come agente antibatterico 192
Procedimento per la produzione di esteri metilici di acidi grassi per reazione di trigliceridi di origine naturale con alcol metilico in presenza di resine 191
Nutritional supplement, especially for dairy products, comprises leptin. 190
AMINOPYRROLE DERIVATIVES 187
Use of microparticles for antigen delivery 186
Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments 185
DERIVATIVES OF [(3-HYDROXY-4-PYRON-2-YL)-METHYL]-AMINE AND USE THEREOF AS ANTI-NEOPLASTIC DRUGS 184
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 183
A process for obtaining chemically defined and reproducible polydeoxyribonucleotides. 182
DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS. 181
Derivati 2-Acilamminoalchilindolici come Antagonisti/Agonisti Parziali della Melatonina 179
Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor ant their use as medicaments 175
Preparation of glutathione derivatives as antiviral agents 174
PYRROLO[3,4-d]PYRIMIDINES 173
ANTIINFLAMMATORY OXAZOLES 171
“ ,Processo de producao de antioxidante alquilado, obtido a partir de fenois, cresois e preferencialmente do cardanol hidrogenado, 3-pentadecilfenol (3-PDP) aplicavel como aditivo em combustiveis e lubrificantes. “ 168
PYRROLO[3,4-d]PYRIMIDINES 167
DERIVATI DI [(3-IDROSSI-4-PIRON-2-IL)METIL]-AMINA E LORO USO COME FARMACI ANTI-NEOPLASTICI 167
PROCEDIMENTO DI SELEZIONE AUTOMATICA DI FOTOGRAFIE DIGITALI DA UN ARCHIVIO PER LA CREAZIONE AUTOMATICA DI UNA SEQUENZA DI FOTO CHE RAPPRESENTA UNA STORIA EMOZIONALE DA STAMPARE E/O CONSERVARE 167
PREPARATION OF ANELLATED CARBAPENEMS AS ANTIBIOTICS 164
PREPARATION OF 3-UREIDO-2,4-DIOXOTETRAHYDRO-1,5-BENZODIAZEPINES AS CCK AND GASTRIN ANTAGONISTS 163
3,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(1H)-ONE DERIVATIVES 163
Derivato tetramerico dell'indol-3-carbinolo ad attività anticancerogena e metodo di sintesi del derivato stesso 163
USE OF ISOLATED MATURE ADIPOCYTES IN REGENERATIVE MEDICINE FOR THE RECONSTRUCTION AND REPARATION OF TISSUES 163
3-AMINO-4-CARBAMYLPYRROLE DERIVATIVES 161
Procedimento di valutazione automatica della qualità di foto digitali 161
PHARMACOLOGICALLY ACTIVE PYRROLODIAZEPINES 159
PREPARATION AND TESTING OF N15-ALKYL AND N15,N15-DIALKYL DERIVATIVES OF TEICOPLANIN COMPOUNDS AS BACTERICIDES 159
Derivati 1-Acilamminoalchilindolici come agonisti della melatonina. 158
Procedimento per la produzione di derivati t-butilati del cardanolo e del 3-n-pentadecilfenolo 156
PREPARATION OF 13-DE(ACETAMIDOGLUPYRANOSYL)-34-DEOXYTEICOPLANIN DERIVATIVES AS ANTIBACTERIALS 155
Derivati fosforilati del cardanolo o del 3-n-pentadecilfenolo utili come additivi per lubrificanti e procedimento per la loro preparazione. 155
AMINOPYRROLE DERIVATIVES 154
PYRROLODIAZEPINES 153
Nanosfere polimeriche e relativo utilizzo per veicolare oligonucleotidi. 152
PYRROLODIAZEPINE DERIVATIVES 150
PYRROLO[3,4-b]PYRIDINES 150
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 145
Procedimento per la produzione di antiossidanti solforati da derivati dell'olio del guscio della noce di anacardio. 142
Nuovo procedimento per la raffinazione dell'olio derivato dai gusci delle noci di anacardio e prodotto ottenuto con tale procedimento. 142
Preparation of 2-trichloroacetoxy-3,4,5,6-tetrachlorobenzoic acid and compositions containing same for treating benign mammalian neoformations. 141
Methods, Compositions, and Other Compounds for Modulation of Monoacylglycerol Lipase Pain, and Stress-related Disorders 141
MACCHINA PER ANALISI CHIMICA COMPRENDENTE LA COMBINAZIONE DELLA SPETTROMETRIA DI MASSA A IONIZZAZIONE ELETTRONICA CON LA CROMATOGRAFIA LIQUIDA 140
PREPARATION OF DE(ACETYLGLUCOSAMINYL)DIDEHYDRODEOXYTEICOPLANIN DERIVATIVES AS ANTIBIOTICS 138
Preparation of heterocyclic compounds as fluorescent probes for detection in biological systems 137
Manufacture of antioxidants for rubbers from phenolic pitch. 136
ANTIINFLAMMATORY 4,5-OXAZOLEDICARBOXAMIDES 136
Inhibitors of anandamide transport and their therapeutic use 133
Procedimento per la preparazione di derivati perfluorurati del cardanolo utili come intermedi organici, idrorepellenti, impregnanti, insetticidi, fitofarmaci e precursori di bisfenoli, resine fenoliche o resine fenoliche modificate. 132
Derivati del glutatione e loro utilizzi per il trattamento di malattie virali 131
Novel melatonin ligands having antidepressant activity as well as sleep inducine properties 130
PREPARATION OF 22-DECHLOROTEICOPLANIN AS ANTIBACTERIALS 125
Filter for the equalization and/or linearization of non-Linear systems 125
Preparation and anticancer activity of tetramerous deriv. of indole-3-carbinol. 124
Totale 25.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.090 0 109 146 244 29 8 34 59 88 44 13 316
2022/20232.093 253 177 137 225 152 482 8 173 266 45 123 52
2023/2024625 56 62 29 51 41 152 39 65 3 35 17 75
2024/20251.768 152 64 434 117 49 112 151 108 180 97 193 111
2025/20269.366 390 851 1.565 623 338 340 676 132 3.992 181 197 81
2026/2027167 107 60 0 0 0 0 0 0 0 0 0 0
Totale 26.034